Clinical usage of hypolipidemic and antidiabetic drugs in the prevention and treatment of cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (84)
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin
2002 • 18,132 citations
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
1994 • 8,631 citations
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
1998 • 7,971 citations
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 • 6,780 citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 • 5,293 citations
Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance
2003 • 2,035 citations
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
1998 • 1,728 citations
Insulin-like growth factors and neoplasia
2004 • 1,452 citations
Pathophysiology of insulin resistance in human disease
1995 • 1,239 citations
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
2003 • 869 citations
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
2002 • 859 citations
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999 • 797 citations
Weight Loss in Breast Cancer Patient Management
2002 • 604 citations
PPARα Agonist-Induced Rodent Tumors: Modes of Action and Human Relevance
2003 • 600 citations
The statins as anticancer agents.
2003 • 595 citations
Genetic cause of hyperglycaemia and response to treatment in diabetes
2003 • 583 citations
Insulin Resistance as a Predictor of Age-Related Diseases
2001 • 579 citations
Orlistat Is a Novel Inhibitor of Fatty Acid Synthase with Antitumor Activity
2004 • 570 citations
Adiponectin and Breast Cancer Risk
2004 • 534 citations
The Risk of Cancer in Users of Statins
2004 • 514 citations
Pharmacogenetic Study of Statin Therapy and Cholesterol Reduction
2004 • 455 citations
Globalization, coca-colonization and the chronic disease epidemic: can the Doomsday scenario be averted?
2000 • 449 citations
Risk Factors for Advanced Colonic Neoplasia and Hyperplastic Polyps in Asymptomatic Individuals
2003 • 436 citations
Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonists
2004 • 433 citations
A Prospective Study of Plasma C-Peptide and Colorectal Cancer Risk in Men
2004 • 333 citations
Metformin
2003 • 314 citations
Leptin Enhances, via AP-1, Expression of Aromatase in the MCF-7 Cell Line
2003 • 281 citations
Cholesterol and prostate cancer
2003 • 266 citations
Reducing insulin resistance with metformin: the evidence today
2003 • 257 citations
Safety and Tolerability of Pravastatin in Long-Term Clinical Trials
2002 • 241 citations
Statin Therapy, Cardiovascular Events, and Total Mortality in the Heart and Estrogen/Progestin Replacement Study (HERS)
2002 • 234 citations
Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study
2003 • 230 citations
Modulation of Circulating and Adipose Tissue Adiponectin Levels by Antidiabetic Therapy
2003 • 228 citations
Weight Loss in Breast Cancer Patient Management
2002 • 227 citations
Metabolic Effects of Rosiglitazone in HIV Lipodystrophy
2004 • 215 citations
Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy.
2000 • 191 citations
Potential antitumor effects of statins (Review)
2003 • 191 citations
The Insulin-Related Ovarian Regulatory System in Health and Disease
1999 • 189 citations
Risk of endometrial and breast cancer in patients with diabetes mellitus
1997 • 188 citations
The nicotinic acid receptor–a new mechanism for an old drug
2004 • 187 citations
Abnormal Glucose Tolerance and the Risk of Cancer Death in the United States
2003 • 182 citations
Membrane fluidity in malignancy Adversative and recuperative
1984 • 167 citations
A phase II trial with rosiglitazone in liposarcoma patients
2003 • 161 citations
An intracellular modulation of free radical production could contribute to the beneficial effects of metformin towards oxidative stress
2003 • 159 citations
Effect of statins combined with estradiol on the proliferation of human receptor-positive and receptor-negative breast cancer cells
2003 • 152 citations
Lipid-Lowering Drug Use and Breast Cancer in Older Women: A Prospective Study
2003 • 147 citations
Serum Cholesterol and Cancer Risk: An Epidemiologic Perspective
1992 • 147 citations
Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome
2004 • 142 citations
A Ligand of Peroxisome Proliferator-Activated Receptor gamma, Retinoids, and Prevention of Preneoplastic Mammary Lesions
2000 • 142 citations
Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
1985 • 129 citations
Insulin Resistance as a Predictor of Age-Related Diseases
2001 • 128 citations
Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells
2003 • 120 citations
The association between 3‐hydroxy‐3‐methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women
2004 • 115 citations
Importance of Adipocytokines in Obesity-Related Diseases
2003 • 114 citations
The metabolic syndrome in long-term cancer survivors, and important target for secondary preventive measures
2002 • 111 citations
Insulin and longevity: antidiabetic biguanides as geroprotectors.
2003 • 95 citations
Birth weight and risk of early-onset breast cancer (Denmark).
2003 • 93 citations
Statin use and the risk of breast cancer
2003 • 92 citations
Effects of comicronised fenofibrate on lipid and insulin sensitivity in patients with polymetabolic syndrome X
2000 • 87 citations
HMG CoA reductase inhibitors and the risk of colorectal cancer
2004 • 81 citations
Proposed Treatment of Cancer by Inhibition of Gluconeogenesis
1968 • 80 citations
Niacin and Carcinogenesis
2003 • 78 citations
Development, aging, and disease : a new rationale for an intervention strategy
1994 • 75 citations
Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent
2003 • 72 citations
Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C‐reactive protein in subjects with impaired fasting glucose
2003 • 63 citations
Metabolomics Takes Its Place as Latest Up-and-Coming "Omic" Science
2004 • 63 citations
Effects of phenformin on the proliferation of human tumor cell lines
2003 • 45 citations
law of deviation of homeostasis and diseases of aging
1981 • 45 citations
Treatment of PCOS with metformin and other insulin-sensitizing agents
2004 • 43 citations
Does Lowering Cholesterol Cause Cancer?
1996 • 43 citations
Carcinogenicity of lipid-lowering drugs
1996 • 43 citations
Melanoma Chemoprevention: A Role for Statins or Fibrates?
2003 • 40 citations
Preliminary evidence on metabolic rehabilitation of cancer patients.
1988 • 35 citations
Newborn Macrosomy And Cancer
1988 • 32 citations
Metabolic Immunodepression and Metabolic Immunotherapy
1982 • 32 citations
Molecular Regulation of Cholesterol Biosynthesis: Implications in Carcinogenesis
2003 • 29 citations
Hypolipidemic therapy and cholesterol absorption
2004 • 22 citations
Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease
2003 • 19 citations
[Cholesterolemia and total, cardiovascular and cancer mortality. Study of a cohort of 220,000 people].
1998 • 11 citations
Does lowering cholesterol cause cancer?
1996 • 5 citations
Cancer proneness profile. A study in ponderal index and blood glucose.
1969 • 5 citations
Studies on the antitumoral activity of the biguanides. V.
1967 • 2 citations
Effects of Misclerone (Clofibrate) on Dimethylhydrazine-Induced Intestinal Carcinogenesis in Rats
1982 • 2 citations
Deleted Work
1955 • 0 citations